Endocrine & Incretin Research Bundle | GLP‑3 + Tesamorelin 5mg (RUO)

Description

Overview
This research bundle pairs two peptides examined individually in preclinical
literature for their interactions with endocrine receptor families and downstream
signalling cascades. Supplied in lyophilised form for laboratory research use only.

Bundle Contents
– GLP‑3 5mg — incretin‑related receptor binding and enteroendocrine signalling models
– Tesamorelin 5mg — GHRH analog; GHRH receptor interactions and cAMP/PKA signalling
in pituitary axis model systems

Research Context
– Components investigated individually in controlled models assessing GPCR receptor
binding, incretin‑related pathways, and hypothalamic–pituitary signalling markers.
– Each compound supplied with independent lot documentation.
– Findings are model‑specific and limited to defined experimental settings.

Format and Documentation
– Two lyophilised vials; nominal content 5mg per vial as labelled
– Certificate of Analysis (COA) provided for each lot
– Storage guidance for research environments on label/COA

Compliance
For laboratory research use only (RUO). Not for human or veterinary use, diagnostic
or therapeutic applications.

FAQ
What compounds are included?
GLP‑3 5mg and Tesamorelin 5mg — each supplied as a separate lyophilised vial with
individual COA.

Do all vials come with a COA?
Yes — a Certificate of Analysis is provided for each lot in the bundle.

How should these be stored in a lab?
Follow the label/COA storage guidance for each individual vial.

Form: Lyophilised powder
Intended use: Laboratory research use only
Documentation: Certificate of Analysis where applicable
Dispatch: Fast UK fulfilment
Storage:
– Powder: -20°C 3 years ; 4°C 2 years ; 15°C 3 month
– In solvent: -80°C 6 months ; -2°C 1 month ; 10°C 1 week

Product disclaimer
This product is supplied strictly for laboratory research use only. Not for human or veterinary